Zobrazeno 1 - 10
of 94
pro vyhledávání: '"Marie, Kostine"'
Autor:
Céline Eldani, Marie Kostine, Maxime Faure, Estibaliz Lazaro, Claire Rigothier, Jean Baptiste Hiriart, Bérénice Teulières, Florian Poullenot, Magalie Haissaguerre, Maeva Zysman, Rémi Veillon, Charlotte Vergnenegre, Nahema Issa, Charlotte Domblides, Sorilla Mary-Prey, Marie Beylot-Barry, Anne Pham-Ledard, Caroline Dutriaux, Guilhem Sole, Fanny Duval, Emilie Gerard
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
Immune checkpoint inhibitors (ICIs) present clinicians with the challenge of managing immune-related adverse events (irAEs), which can range from mild to severe due to immune system activation 1. While guidelines recommend discontinuing ICIs for grad
Externí odkaz:
https://doaj.org/article/dc9286fc8fa7429d8cc121e94b05face
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
IntroductionCombination molecular BRAF/MEK inhibitors targeted therapy has been shown to improve overall survival in patients with BRAF V600 mutated unresectable or metastatic melanoma. Most patients treated with BRAF/MEK inhibitors will experience a
Externí odkaz:
https://doaj.org/article/b125cbbb052e43b09e1cdf5a605b861c
Autor:
Samuel Bitoun, Marie Kostine, Christophe Richez, Thomas Barnetche, Thierry Schaeverbeke, Gael Mouterde, Marie-Elise Truchetet, Maéva Zysman, Amaury Daste, Sorilla Prey, Alice Tison, Rémi Veillon, Caroline Dutriaux, Anne Pham-Ledard, Marie Beylot-Barry, Marine Gross-Goupil, Félix Lefort, Alexandra Ladouceur, Emilie Gerard, Charlotte Domblides, Baptiste Sionneau, Mathieu Larroquette
Publikováno v:
RMD Open, Vol 9, Iss 4 (2023)
Objective Another course of immune checkpoint inhibitors (ICIs) is often considered in patients with cancer progression and previous immune-related adverse events, including inflammatory arthritis (ICI-IA), but there are limited data regarding safety
Externí odkaz:
https://doaj.org/article/dd729db8de80406ebd7112cf82a7704c
Autor:
Léa Dousset, MD, Alize Pacaud, MD, Thomas Barnetche, PhD, Marie Kostine, MD, PhD, Caroline Dutriaux, MD, Anne Pham-Ledard, MD, PhD, Marie Beylot-Barry, MD, PhD, Emilie Gérard, MD, Sorilla Prey, MD, PhD, Nicolas Andreu, BSc, Katia Boniface, PhD, Julien Seneschal, MD, PhD
Publikováno v:
JAAD International, Vol 5, Iss , Pp 112-120 (2021)
Background: Clinical factors associated with vitiligo in patients receiving anti–programmed cell death-1 (PD-1) remain unknown. Objective: To better characterize the occurrence of vitiligo in patients receiving anti–PD-1. Methods: The present sin
Externí odkaz:
https://doaj.org/article/76be4dd06db242e08a19309ca7ae10ba
Autor:
Marie Kostine, Christophe Richez, Thierry Schaeverbeke, Gael Mouterde, Marie-Elise Truchetet, Julien Henry, Rakiba Belkhir, Vincent Germain, Isabelle Bonnet, Chi Duc Nguyen, Thao Pham, Claire Brière, Léa Rouxel, Thierry Cardon, Fanny De La Fuente, Pierre Edouard Gavand, Céline Labadie, Ambre Lauret
Publikováno v:
RMD Open, Vol 8, Iss 2 (2022)
Objective There is limited experience regarding the use of biological disease-modifying antirheumatic drug (bDMARD) and JAK inhibitor (JAKi) for the management of immune checkpoint inhibitors (ICI)-induced inflammatory arthritis. We aimed to assess t
Externí odkaz:
https://doaj.org/article/eed9e3a2d1ea4e8facaa4a0b25a6ee55
Autor:
Guillaume Manson, Alexandre Thibault Jacques Maria, Florence Poizeau, François-Xavier Danlos, Marie Kostine, Solenn Brosseau, Sandrine Aspeslagh, Pauline Du Rusquec, Maxime Roger, Maud Pallix-Guyot, Marc Ruivard, Léa Dousset, Laurianne Grignou, Dimitri Psimaras, Johan Pluvy, Gilles Quéré, Franck Grados, Fanny Duval, Frederic Bourdain, Gwenola Maigne, Julie Perrin, Benoit Godbert, Beatris Irina Taifas, Alexandra Forestier, Anne-Laure Voisin, Patricia Martin-Romano, Capucine Baldini, Aurélien Marabelle, Christophe Massard, Jérôme Honnorat, Olivier Lambotte, Jean-Marie Michot
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-12 (2019)
Abstract Background Paraneoplastic syndromes (PNS) are autoimmune disorders specifically associated with cancer. There are few data on anti-PD-1 or anti-PD-L1 immunotherapy in patients with a PNS. Our objective was to describe the outcome for patient
Externí odkaz:
https://doaj.org/article/ca72d3ba97984c078f0aec5f8467a55e
Autor:
Raphael Borie, Marie Pierre Debray, Alexis F. Guedon, Arsene Mekinian, Louis Terriou, Valentin Lacombe, Estibaliz Lazaro, Aurore Meyer, Alexis Mathian, Samuel Ardois, Guillaume Vial, Thomas Moulinet, Benjamin Terrier, Yvan Jamilloux, Mael Heiblig, Jean-David Bouaziz, Eve Zakine, Roderau Outh, Sylvie Groslerons, Adrien Bigot, Edouard Flamarion, Marie Kostine, Pierrick Henneton, Sebastien Humbert, Arnaud Constantin, Maxime Samson, Nadine Magy Bertrand, Pascal Biscay, Celine Dieval, Herve Lobbes, Juliette Jeannel, Amelie Servettaz, Leo Adelaide, Julie Graveleau, Benjamin de Sainte-Marie, Joris Galland, Vivien Guillotin, Eugénie Duroyon, Marie Templé, Rim Bourguiba, Sophie Georgin Lavialle, Olivier Kosmider, Alexandra Audemard-Verger, Julien Haroche, Zahir Amoura, Micheline Pha, Miguel Hie, Kilifa Meghit, Murielle Rondeau-Lutz, Jean-Christophe Weber
Publikováno v:
Chest. 163:575-585
The vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome is a newly identified autoinflammatory disorder related to somatic UBA1 mutations. Up to 72% of patients may show lung involvement.What are the pleuropulmonary manifestatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c6a0c35139847311e222e7d7257f29e
https://doi.org/10.1016/j.chest.2022.10.011
https://doi.org/10.1016/j.chest.2022.10.011
Autor:
Sofia Ramiro, John D Pauling, Marie Kostine, Christophe Richez, Alexandre Sepriano, Alessia Alunno, Paul Studenic, Elena Nikiphorou, Aurélie Najm, Javier Rodríguez-Carrio, Evelyn Smith, Ana Carina Ferreira, Kate Stevens, Ibon Eguiluz-Gracia
Publikováno v:
RMD Open, Vol 6, Iss 2 (2020)
Background Multidisciplinary collaboration is defined as a collective work involving multiple disciplines and is common in clinical care and research. Our aim was to describe current clinical and research collaboration among young specialists and to
Externí odkaz:
https://doaj.org/article/d466b70f700a4b1d8dc517db62455255
Publikováno v:
Nature Reviews Rheumatology. 18:641-656
Immune-checkpoint inhibitors (ICIs) have dramatically changed the management of advanced cancers. Designed to enhance the antitumour immune response, they can also cause off-target immune-related adverse events (irAEs), which are sometimes severe. Al
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::448aa74b0dc6991ebd7d5dd62dbfa033
https://doi.org/10.1038/s41584-022-00841-0
https://doi.org/10.1038/s41584-022-00841-0
Autor:
Antonello Veccia, Marie Kostine, Alice Tison, Mariachiara Dipasquale, Stefania Kinspergher, Larry Prokop, Guido Grandi, Sandro Inchiostro, Orazio Caffo, Giuseppe Paolazzi, Roberto Bortolotti, Divi Cornec, Alvise Berti
Publikováno v:
Revue du Rhumatisme. 89:447-457
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e6265efe800783303cd6f40d1c68a6c5
https://doi.org/10.1016/j.rhum.2022.07.020
https://doi.org/10.1016/j.rhum.2022.07.020